[3 cases of essential blepharospasm: pathogenetic problems correlated].
Three clinical cases of essential blepharospasm are discussed. On the basis of both therapeutical results and a review of the literature, pathogenetic hypothesis concerning such pathology are reexamined.
D001764:Blepharospasm / Q000175:diagnosis* / Q000188:drug therapy / Q000209:etiology; D001960:Bromazepam / Q000627:therapeutic use; D002998:Clonazepam / Q000627:therapeutic use; D003937:Diagnosis, Differential; D003975:Diazepam / Q000031:analogs & derivatives / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005141:Eyelid Diseases / Q000175:diagnosis*; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000502:physiology; D014282:Trihexyphenidyl / Q000627:therapeutic use
D018377:Neurotransmitter Agents; D002998:Clonazepam; D014282:Trihexyphenidyl; D006220:Haloperidol; D003975:Diazepam; D001960:Bromazepam
Tre casi di blefarospasmo essenziale: problemi patogenetici correlati.